Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women.
The purpose of this study was to examine insulin resistance, markers of the metabolic syndrome, cardiovascular disease (CVD) risk, and serum adiponectin concentrations in pre-menopausal Hispanic and non-Hispanic White (NHW) women. This cross-sectional study examined 119 pre-menopausal women (76 Hispanic, 45 NHW) for markers of the metabolic syndrome (ATP III criteria), level of insulin resistance (HOMA-IR), CVD risk factors, and serum total adiponectin concentrations. Relationships between variables were assessed using Student's t-tests, Pearson's and Spearman's Rho correlations, and stepwise multiple regression analysis. Hispanic women had significantly lower adiponectin concentrations than NHW women, even after controlling for body fat (%) (P < 0.01). Number of markers of the metabolic syndrome was inversely related to total adiponectin concentration for all women combined and for NHW women (P ≤ 0.04), but not for Hispanic women. Insulin resistance was inversely related to adiponectin for all women and for NHW women (P < 0.01), but not significantly associated in Hispanic women. Adiponectin concentration was not significantly associated with number of CVD risk factors for these women. While adiponectin was associated with markers of metabolic syndrome and insulin resistance for all women of this study and despite lower adiponectin concentrations for Hispanic women than NHW women, the role of adiponectin to these conditions among Hispanics remains unclear. There was no significant association between adiponectin and CVD risk for these women. Future research should focus on understanding mechanisms for up-regulating adiponectin secretion and if ethnicity affects adiponectin gene expression and secretion given the beneficial effects derived from elevated adiponectin levels.
King
George A
GA
Department of Kinesiology, The University of Texas at El Paso, 1101 N Campbell St, El Paso, TX 79902, USA. gking@utep.edu
Deemer
Sarah E
SE
Thompson
Dixie L
DL
D052242:Adiponectin / Q000097:blood*; D000328:Adult; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000097:blood* / Q000453:epidemiology / Q000208:ethnology; D003430:Cross-Sectional Studies; D005260:Female; D006630:Hispanic or Latino; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000097:blood* / Q000453:epidemiology / Q000208:ethnology; D008875:Middle Aged; D012307:Risk Factors; D014481:United States / Q000453:epidemiology / Q000208:ethnology; D044465:White People
D052242:Adiponectin; D015415:Biomarkers
Scand J Clin Lab Invest. 2007;67(5):449-58
17763181
JAMA. 2002 Jan 16;287(3):356-9
11790215
Metabolism. 2004 Jan;53(1):1-3
14681833
Timely Top Med Cardiovasc Dis. 2008 Feb 04;12:E3
18392213
Eur Heart J. 2005 Aug;26(16):1640-6
15932907
Ann Med. 2001 Nov;33(8):534-41
11730160
Int J Obes (Lond). 2008 May;32(5):740-8
18180784
Diabetes. 2008 Apr;57(4):980-6
18192541
Transl Res. 2007 Jun;149(6):317-23
17543850
J Clin Endocrinol Metab. 2005 Oct;90(10):5677-83
16076942
Am J Epidemiol. 2007 Jan 15;165(2):164-74
17101706
NCHS Data Brief. 2007 Nov;(1):1-8
19389313
Ann Intern Med. 2008 Sep 2;149(5):307-16
18765700
J Clin Endocrinol Metab. 2007 Jul;92(7):2665-71
17426091
Curr Opin Lipidol. 2002 Feb;13(1):51-9
11790963
Vasc Health Risk Manag. 2007;3(6):853-76
18200806
Am J Hum Genet. 2004 May;74(5):979-1000
15088269
Am J Cardiol. 2006 Dec 15;98(12):1603-8
17145218
Pharmacol Res. 2007 Dec;56(6):459-67
18029194
Circulation. 2003 Sep 30;108(13):1546-51
14517150
J Clin Endocrinol Metab. 2004 Jun;89(6):2595-600
15181029
JAMA. 2009 Jul 8;302(2):179-88
19584347
J Clin Invest. 2007 Sep;117(9):2621-37
17717599
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):29-33
14551151
J Biol Chem. 1995 Nov 10;270(45):26746-9
7592907
J Clin Endocrinol Metab. 2008 Oct;93(10):4075-9
18682512
Nutr Rev. 2003 Aug;61(8):290-2
13677592
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):e15-6
15731480
Circulation. 2004 Apr 20;109(15):1809-12
15096460
J Clin Endocrinol Metab. 2001 May;86(5):1930-5
11344187
Int J Obes (Lond). 2007 May;31(5):770-6
17117187
Diabetes Obes Metab. 2007 May;9(3):282-9
17391153
Diabetologia. 1985 Jul;28(7):412-9
3899825